Drug discovery for idiopathic pulmonary fibrosis
Ended Project Grant Awarded Last action
- Award ID
- R43HL142407
- Recipient
-
Covenant Therapeutics LLC UEI KKJLPNVZZWT2
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $217,420
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Virginia, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $5,843 | |
| Amendment | $5,843 | |
| Amendment | -$6,312 | |
| Amendment | -$6,312 | |
| Amendment | -$6,312 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $224,669 |
Quick answers
Who received award R43HL142407?
R43HL142407 was awarded to Covenant Therapeutics LLC by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2018.
How much is award R43HL142407 worth?
$217,420 has been obligated on R43HL142407.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award